| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/05/2015 | WO2015031710A1 Compositions and methods for the treatment of metabolic and body weight related disorders |
| 03/05/2015 | WO2015031709A1 Rapid acting injectable formulations comprising a peptide and a vasodilatory agent |
| 03/05/2015 | WO2015031089A1 Nutraceutical combination for prevention and treatment of type 2 diabetes |
| 03/05/2015 | WO2015030336A1 Composition containing composite extract of grape and schisandra chinensis for preventing or treating metabolic syndrome-related diseases |
| 03/05/2015 | WO2015030293A1 Composition containing composite extract of grape and schisandra chinensis for preventing or treating metabolic syndrome-related diseases |
| 03/05/2015 | WO2015030033A1 Therapeutic agent for dyslipidemia |
| 03/05/2015 | WO2015029966A1 ω3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID |
| 03/05/2015 | WO2015029066A1 Polymorphic form of pyrrole derivative and intermediate thereof |
| 03/05/2015 | WO2015028960A1 Substituted heterocyclic derivatives as gpr agonists and uses thereof |
| 03/05/2015 | WO2015028956A1 Compositions and methods for the treatment of fatty acid oxidation disorders |
| 03/05/2015 | WO2015028927A1 Compositions and methods for the treatment of metabolic diseases |
| 03/05/2015 | WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors |
| 03/05/2015 | WO2015028456A1 PPAR modulators |
| 03/05/2015 | WO2015027963A1 Aromatic ring derivative, and pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027911A1 Compound for treating diabetes |
| 03/05/2015 | WO2015027820A1 Use of human nectin-2 protein |
| 03/05/2015 | WO2015027730A1 Traditional chinese medicine complex composite significantly increasing serum high density lipoprotein concentration, and preparation method |
| 03/05/2015 | WO2015027652A1 A novel antidiabetic drug |
| 03/05/2015 | WO2015027565A1 L-carnitine micro-capsule powder and preparation method thereof |
| 03/04/2015 | EP2842969A1 Lactoferrin fusion protein and method for producing same |
| 03/04/2015 | EP2842950A1 Method for producing composition containing fucoxanthin |
| 03/04/2015 | EP2842938A1 Novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient |
| 03/04/2015 | EP2842937A1 Amine compound and use thereof for medical purposes |
| 03/04/2015 | EP2842931A1 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof |
| 03/04/2015 | EP2842568A1 Pharmaceutical composition for treating and/or preventing type i diabetes and application thereof |
| 03/04/2015 | EP2842563A1 A composition comprising powdered eggshell membrane for use in treating a pre-diabetic mammals. |
| 03/04/2015 | EP2842561A1 Enteral environment-improving agent |
| 03/04/2015 | EP2842558A1 Cgrp responsiveness promoter |
| 03/04/2015 | EP2842555A2 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines in the treatment of diabetes |
| 03/04/2015 | EP2841432A1 Tetrahydropyran dgat1 inhibitors |
| 03/04/2015 | EP2841419A1 Crystalline forms of saxagliptin |
| 03/04/2015 | EP2841080A1 Composition for treating metabolic disorders |
| 03/04/2015 | EP2841077A1 Dietary fiber compositions for the treatment of metabolic disease |
| 03/03/2015 | US8969371 Compositions and methods for weight loss in at risk patient populations |
| 03/03/2015 | US8969293 Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 03/03/2015 | US8969288 Amide based glucagon and superfamily peptide prodrugs |
| 02/26/2015 | WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015027015A1 Imidazole-derived modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015026922A1 Alkyl derivatives as sphingosine-1 phosphate receptors modulators |
| 02/26/2015 | WO2015026380A1 Composition for treating ocular effects of diabetes |
| 02/26/2015 | WO2015026245A1 Beta-casein a2 and blood glucose levels |
| 02/26/2015 | WO2015025816A1 Chymase inhibitor and medicine comprising chymase inhibitor |
| 02/26/2015 | WO2015025815A1 Polyrotaxane and medicinal composition |
| 02/26/2015 | WO2015024526A1 Carboxylic acid compounds in treatment of diabetes mellitus |
| 02/26/2015 | WO2015024486A1 Dgat1 inhibitor and preparation method and use thereof |
| 02/26/2015 | WO2015024448A1 Benzo piperidine ring and benzo morpholine ring compounds, manufacturing method therefor, and medical applications thereof |
| 02/25/2015 | EP2839004A1 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation |
| 02/25/2015 | EP2838907A2 Aminosteroids for the treatment of a ptp1b associated disease |
| 02/25/2015 | EP2838906A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors |
| 02/25/2015 | EP2838892A1 Methods of producing anamorelin hydrochloride having controlled chloride content |
| 02/25/2015 | EP2838891A1 Aromatic ring compound |
| 02/25/2015 | EP2838888A1 Thiadiazolidinediones as gsk-3 inhibitors |
| 02/25/2015 | EP2838528A1 Methods for inhibition of shc-1/p66 to combat aging-related diseases |
| 02/25/2015 | EP2838522A1 Treatment of medium-chain acyl-coa dehydrogenase deficiency |
| 02/24/2015 | US8962553 Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide |
| 02/24/2015 | US8962036 Disintegrable formulations of lanthanum carbonate |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962020 Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
| 02/24/2015 | US8962015 Orally bioavailable lipid-based constructs |
| 02/24/2015 | CA2683534C Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
| 02/24/2015 | CA2658633C Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 02/24/2015 | CA2631850C Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 02/24/2015 | CA2594233C Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 02/23/2015 | CA2824681A1 Nutritional supplements for pregnant women |
| 02/19/2015 | WO2015022978A1 Fat accumulation inhibitor, drug, prophylactic or therapeutic agent for fatty liver, food or drink, and method for producing fat accumulation inhibitor |
| 02/19/2015 | WO2015022962A1 Lipid metabolism accelerator |
| 02/19/2015 | WO2015022930A1 Lipid absorption promoter comprising scallop mantle protein decomposition product as active ingredient, and food and drink containing same |
| 02/19/2015 | WO2015022927A1 Amp-activated protein kinase activator |
| 02/19/2015 | WO2015022909A1 Ghg-containing composition and fat absorption inhibitor using same |
| 02/19/2015 | WO2015022631A1 Substituted biphenyl compounds as calcium sensing receptor modulators |
| 02/19/2015 | WO2015022546A1 Inhibitors of plasma kallikrein |
| 02/19/2015 | WO2015021894A1 Novel hydroximic acid derivative and medical application thereof |
| 02/19/2015 | WO2015021871A1 Antibody specifically binding to glp-1r and fusion protein thereof with glp-1 |
| 02/19/2015 | WO2015021861A1 Stable insulin secretagogue peptide hydro-injection pharmaceutical composition |
| 02/19/2015 | WO2015021631A1 Astragalus seed raw oil, refined oil, preparation method therefore and application thereof |
| 02/19/2015 | WO2015021512A1 Sugar cane derived extracts and methods of treatment |
| 02/19/2015 | WO2014194429A9 Targeted enzyme compounds and uses thereof |
| 02/18/2015 | EP2836500A1 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 02/18/2015 | EP2836490A2 Indole and indazole compounds that activate ampk |
| 02/17/2015 | US8957073 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 02/17/2015 | US8957065 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 02/17/2015 | US8957021 Glucose-regulating polypeptides and methods of making and using same |
| 02/17/2015 | CA2710977C 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 02/17/2015 | CA2679971C Glucokinase activator |
| 02/17/2015 | CA2669524C Collagen peptide composition and food or beverage containing the same |
| 02/17/2015 | CA2664112C Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 02/17/2015 | CA2662209C Implantable devices for producing insulin |
| 02/17/2015 | CA2649842C Composition containing peptide as active ingredient |
| 02/17/2015 | CA2612176C Dihydrothieno[2,3-d]pyramidine-6-carboxylic acid derivatives as pde9 inhibitors |
| 02/17/2015 | CA2592532C Sesamin/episesamin compositions with improved bioavailability |
| 02/17/2015 | CA2557151C Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity |
| 02/16/2015 | CA2851952A1 Supplement composition and methods of use |
| 02/12/2015 | WO2015021141A1 Methods of treating a cardiovascular disorder in a subject on apo-c3 modulating therapy |
| 02/12/2015 | WO2015020194A1 Antisense oligonucleotide against acsl1 |
| 02/12/2015 | WO2015020186A1 Tablet composition |
| 02/12/2015 | WO2015020184A1 Aromatic compound |
| 02/12/2015 | WO2015020138A1 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same |
| 02/12/2015 | WO2015018356A1 Diarylhydantoin derivative, and preparation method, pharmaceutical composition, and application thereof |
| 02/12/2015 | WO2015018343A1 Medicine composition for wound therapy |
| 02/12/2015 | WO2015018128A1 Hypoglycemic chinese medicine preparation and preparation method therefor |